Efficacy of folic acid supplementation in stroke prevention: a meta-analysis

  title={Efficacy of folic acid supplementation in stroke prevention: a meta-analysis},
  author={Xiaobin Wang and Xianhui Qin and Hakan Demirtas and Jianping Li and Guangyun Mao and Yong Huo and Ningling Sun and Li-sheng Liu and Xiping Xu},
  journal={The Lancet},

Figures and Tables from this paper

Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention: A Meta-Analysis

Folic acid supplementation did not demonstrate a major effect in averting stroke, however, potential mild benefits in primary stroke prevention, especially when folate is combined with B vitamins and in male patients, merit further investigation.

Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease

Meta-analysis of folic acid efficacy trials in stroke prevention

Folic acid supplementation could reduce the stroke risk in regions without folic Acid fortification, particularly in trials using a relatively low dosage of folic acid and with low vitamin B12 levels.

Effect of B-vitamin Supplementation on Stroke: a Meta-Analysis of Randomized Controlled Trials

This study indicates that B-vitamin supplementation is not associated with a lower risk of stroke based on relative and absolute measures of association.

Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta‐Analysis of Randomized Controlled Trials

A greater benefit for CVD was observed among participants with lower plasma folate levels and without preexisting CVD and in studies with larger decreases in homocysteine levels, while folic acid supplementation had no significant effect on risk of coronary heart disease.

A Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia

Findings indicated that folic acid supplementation was effective in the primary prevention of CVCE among HT/HHcy patients, as well as reducing the blood pressure and total homocysteine levels.



Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.

Folic acid supplementation has not been shown to reduce risk of cardiovascular diseases or all-cause mortality among participants with prior history of vascular disease and several ongoing trials with large sample sizes might provide a definitive answer.

Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.

The objectives were to ascertain the lowest dose of folic acid associated with the maximum reduction in homocysteine concentrations and to determine the additional relevance of vitamins B-12 and B-6.

Homocysteine lowering with folic acid and B vitamins in vascular disease.

Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease.

Secondary prevention with folic acid: results of the Goes extension study

The results of an open label intervention study with folic acid in a population with stable coronary artery disease while taking stable statin treatment did not appear to attenuate the risk for recurrent events and longer follow up observations are necessary before definite conclusions can be made.

Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial.

It is indicated that supplementation with a multivitamin/mineral combination may have reduced mortality from cerebrovascular disease and the prevalence of hypertension in this rural population with a micronutrient-poor diet.

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease.

A reverse relationship between tHcy and events in ESRD patients is found and administration of high-dose folic acid did not affect event rates.

Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

These randomized trial data from a large cohort of women at high risk of cardiovascular disease indicate that daily supplementation with folic acid, pyridoxine, and cyanocobalamin may reduce the risk of AMD.

Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.

  • M. RighettiG. Ferrario A. Sessa
  • Medicine, Biology
    Medical science monitor : international medical journal of experimental and clinical research
  • 2003
High-dose folic acid treatment did not improve outcome in hyperhomocysteinemia, and 88% of treated patients maintained higher than normal homocysteine levels, and there was a trend towards a decreased rate of cardiovascular events in treated participants as compared to untreated ones.